作者:Jagdish C. Agarwal、Chandishwar Nath、Manju Sharma、Gyan P. Gupta、Krishna P. Bhargava、Kripa Shanker
DOI:10.1002/ardp.19833160808
日期:——
The piperazino derivatives 1–7 were synthesized and evaluated for their antiparkinson activity on oxotremorine‐induced tremors and reserpine‐induced rigidity. The same compounds were screened for their anticonvulsant activity. Compounds 1, 3, 4 and 5 showed promising antiparkinson activity. Maximum activity (10 mg/kg i.p.) was exhibited by compound 3. Its antiparkinson profile is better than that of
合成了哌嗪衍生物 1-7,并评估了它们对氧化震颤素诱发的震颤和利血平诱发的强直的抗帕金森活性。筛选了相同化合物的抗惊厥活性。化合物 1、3、4 和 5 显示出有希望的抗帕金森病活性。化合物3表现出最大活性(10 mg / kg ip)。其抗帕金森病谱优于L-多巴(100 mg / kg ip)和溴隐亭(10 mg / kg ip)。化合物 2、3 和 4 对 MES 的保护率为 90%、80% 和 80%。